About Edanz Evidence Generation
Edanz Evidence Generation provides high-quality evidence generation services in all major therapeutic areas, with particular strengths in endocrinology, neurology and oncology. Edanz was founded in Japan in 1995, and has been providing high quality and cost effective medical and scientific editing, rewriting and publication guidance to the academic and research communities ever since. Edanz joined M3 Group (Tokyo Stock Exchange First Section -securities code 2413) in 2019.
We have a team of international experts with vast industry and medical writing experience. Unlike many other agencies, we are completely transparent about the people in our teams.
*Since May 2020, the Edanz’s medical communications business is known as “Edanz Evidence Generation”.